FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma
Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer
Gleevec First Pediatric Cancer Approval By FDA In 13 Years
FDA Clears Rapid Test For Aspergillus Infection
New Agent Targets Glioma Tumor Cells Prior To Surgery
Fruits, Vegetables Protective Against Cancer, IARC Says
Heavy Smokers And Drinkers Have Different Brain Chemistry
NCI-Approved Clinical Trials
Trending Stories
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors









